All News Roche Holding AG Swiss Exchange

Equities

RO

CH0012032113

Market Closed - Swiss Exchange Other stock markets 11:31:29 2024-06-10 am EDT			5-day change	1st Jan Change
265.4 ^CHF	-1.26%		+3.67%	+1.53%

05:14pm	Global markets live: ABB, Roche, Microsoft, Apple, Tesla...
12:44pm	Roche's Lung Cancer Drug Notches EU Win After 'Unprecedented' Late-stage Study Results	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: ABB, Roche, Microsoft, Apple, Tesla...	11:14am
Roche's Lung Cancer Drug Notches EU Win After 'Unprecedented' Late-stage Study Results	06:44am	MT
Roche: FDA clearance for virus test	03:27am	CF
Roche: EU approval for lung cancer	01:56am	CF
Roche Secures EU Approval for Early-Stage Lung Cancer Treatment	01:27am	MT
Roche Obtains US FDA Emergency Use Permit for Four-in-one Molecular Test	01:26am	MT
Roche: efficacy of Evrysdi in spinal muscular atrophy	Jun. 07	CF
Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	Jun. 07	MT
Five-year Data for Genentech’s Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy (SMA) Achieved or Maintained the Ability to Sit, Stand or Walk	Jun. 07	BU
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	Jun. 07	MT
AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Buy Recommendation	Jun. 06	MT
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	Jun. 06	DJ
The odds of rates getting cut in 2024 may be better than you think	Jun. 05
ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating	Jun. 03	ZD
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	Jun. 03	ZD
Astra's Enhertu breast cancer trial shows 'unprecedented' results	Jun. 02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels	Jun. 02	RE
ROCHE HOLDINGS AG : Gets a Neutral rating from UBS	May. 31	ZD
Transcript : Roche Holding AG - Shareholder/Analyst Call	May. 31
ROCHE HOLDINGS AG : Goldman Sachs remains a Sell rating	May. 30	ZD

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST